As pharmacists administer more vaccines, the risks of needle-stick injury and transmission of a bloodborne disease increase among pharmacists.
Among rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Recently announced changes in vaccine reimbursement under Medicare have implications for pharmacy billing processes.
Biosimilars, which at the most simplistic level can be thought of as a type of generic option for a biologic, offer an opportunity to help reduce total biologic drug spend.
Mr. Mattingly is a third-year professional student in the PharmD Program at the University of Kentucky College of Pharmacy and is dually enrolled in the MBA Program at the Gatton College of Business and Economics.
New treatments with biological agents and vaccines are creating a pathway for patients with metastatic CRC.
Pharmacists can learn about current management of type 2 diabetes mellitus, including updated clinical practice guidelines and the incorporation of new therapeutic classes into practice recommendations.
Did you know that health plans completely cover certain OTC products when patients present a prescription?
There were no signifi cant differences in mean low-density lipoprotein cholesterol levels after patients were converted from fl uvastatin to pravastatin therapy.
The placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.
Demonstrating success is critical to building a long-term care business. How can your pharmacy make a difference?
Gaining the most value from membership requires active participation by techs and a willingness to go outside their comfort zones.
The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
In some circumstances, antihypertensives can play a role in treatment even when a patient's blood pressure readings are normal.
Drug development and innovation could render the current specialty pharmacy model obsolete in 20 years.
Adherence among seniors to 3 widely used chronic medication classes differed by medication burden, patient characteristics, and specific comorbid conditions.
The conduct and interpretation of comparative effectiveness research must build confidence that this research will enable improved access to appropriate healthcare interventions.
There is no greater support team available to students than their pharmacy school.
Advanced behavioral analytics can differentiate patterns of fraud and abuse from instances such as oncology patients receiving multiple prescriptions from different specialists.
Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Mr. Laudien is a financial advisor with Merrill Lynch in Princeton, NJ, member of Securities Investor Protection Corp.
Poor medication compliance in chronic diseases in a well-known public health problem. Pharmacists play a key role in optimizing medication use in patients with chronic conditions.